PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
CD4 112,219 Target Disease Asthma 109,610 1,614 0.01 -0.99 0.01 0.62
CD4 112,219 Target Disease Iron Deficiency Anemia 5,021 16 0.00 -1.00 0.00 0.53
CD4 112,219 Target Disease Sinusitis 12,330 93 0.00 -1.00 0.01 0.56
CD4 112,219 Target Disease Narcolepsy 3,209 7 0.00 -1.00 0.00 0.52
CD4 112,219 Target Disease Brain Tumors 16,749 83 0.00 -1.00 0.00 0.55
CD4 112,219 Target Disease Baldness 865 3 0.00 -1.00 0.00 0.53
CD4 112,219 Target Target AXL 633 3 0.00 -1.00 0.00 0.53
CD4 112,219 Target Disease Chronic Alcoholism 3,068 8 0.00 -1.00 0.00 0.52
CD4 112,219 Target Disease Down Syndrome 10,290 28 0.00 -1.00 0.00 0.53
CD4 112,219 Target Disease Muscle Weakness 9,178 38 0.00 -1.00 0.00 0.54
CD4 112,219 Target Target Hypoxia-Inducible Factor 1-Alpha 923 4 0.00 -1.00 0.00 0.53
CD4 112,219 Target Disease Hyperlipidemia 15,317 63 0.00 -1.00 0.00 0.54
CD4 112,219 Target Disease Memory Loss 2,577 4 0.00 -1.00 0.00 0.51
CD4 112,219 Target Disease Scabies 2,670 19 0.00 -1.00 0.01 0.55
CD4 112,219 Target Disease Muscle Relaxation 4,706 4 0.00 -1.00 0.00 0.49
CD4 112,219 Target Disease Bacterial Infections 14,248 314 0.01 -0.99 0.02 0.60
CD4 112,219 Target Disease Proteinuria 28,803 319 0.01 -0.99 0.01 0.58
CD4 112,219 Target Target Complement Component C1q 167 3 0.00 -0.99 0.02 0.56
CD4 112,219 Target Target BDNF 11,163 26 0.00 -1.00 0.00 0.52
CD4 112,219 Target Disease Dysfunctional Uterine Bleeding 778 1 0.00 -1.00 0.00 0.50
CD4 112,219 Target Target BRAF 4,766 10 0.00 -1.00 0.00 0.52
CD4 112,219 Target Disease Lung Cancer 91,416 379 0.00 -1.00 0.00 0.55
CD4 112,219 Target Target CD34 24,598 988 0.02 -0.98 0.04 0.64
CD4 112,219 Target Target Crth2 Receptor 51 1 0.00 -0.99 0.02 0.55
CD4 112,219 Target Disease Ankylosing Spondylitis 9,665 93 0.00 -0.99 0.01 0.57
CD4 112,219 Target Disease Nephrotic Syndrome 14,681 73 0.00 -1.00 0.00 0.55
CD4 112,219 Target Target CA 50 1,293 2 0.00 -1.00 0.00 0.51
CD4 112,219 Target Target CRG-2 41 6 0.00 -0.92 0.15 0.60
CD4 112,219 Target Target Macrophage Metalloelastase 100 1 0.00 -0.99 0.01 0.54
CD4 112,219 Target Disease Skin Rash 3,684 92 0.00 -0.99 0.02 0.59
CD4 112,219 Target Disease Bipolar Affective Disorder 1,690 1 0.00 -1.00 0.00 0.49
CD4 112,219 Target Target Elastase 13,875 90 0.00 -1.00 0.01 0.55
CD4 112,219 Target Disease Hypothyroidism 23,397 67 0.00 -1.00 0.00 0.53
CD4 112,219 Target Target APO-2L 90 2 0.00 -0.99 0.02 0.56
CD4 112,219 Target Target BMP-2 3,889 3 0.00 -1.00 0.00 0.49
CD4 112,219 Target Disease Seizures 66,465 75 0.00 -1.00 0.00 0.50
CD4 112,219 Target Drug Arranon (Nelarabine)- FDA 12 1 0.00 -0.96 0.08 0.58
CD4 112,219 Target Target DEP-1 88 1 0.00 -0.99 0.01 0.55
CD4 112,219 Target Target Cardiotrophin-1 351 1 0.00 -1.00 0.00 0.52
CD4 112,219 Target Disease Tachyarrhythmia 2,584 1 0.00 -1.00 0.00 0.48
CD4 112,219 Target Disease Onychomycosis 2,201 24 0.00 -0.99 0.01 0.56
CD4 112,219 Target Disease Inflammatory Bowel Diseases 4,684 165 0.01 -0.98 0.04 0.60
CD4 112,219 Target Disease Hyperlipoproteinemia 2,954 2 0.00 -1.00 0.00 0.49
CD4 112,219 Target Disease Leprosy Lepromatous 12 1 0.00 -0.96 0.08 0.58
CD4 112,219 Target Disease Ulcers 45,142 210 0.00 -1.00 0.00 0.55
CD4 112,219 Target Drug Doxycycline 9,324 52 0.00 -1.00 0.01 0.55
CD4 112,219 Target Disease Angioedema 3,997 15 0.00 -1.00 0.00 0.53
CD4 112,219 Target Target CXCL10 2,386 283 0.02 -0.94 0.12 0.64
CD4 112,219 Target Drug Kaempferol 2,992 2 0.00 -1.00 0.00 0.49
CD4 112,219 Target Target CCL8 197 17 0.00 -0.96 0.09 0.60